Jeffrey Kunin is President at NovaBay Pharmaceuticals, Inc. (NBY). They have made 8 open-market trades across 1 company since 2021, most recently 2022-12-06.
CIK 0001738782
5 open-market purchases totalling $362K since 2021, against 3 sales. Across 5 scored buys the stock is down 39.3% at ninety days, and 32.0 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| NBY | 1 | $2 |
Shares reported on the most recent Form 4, priced at the 2022-12-05 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 0% | 0% |
| Avg Move | +1.2% | -15.2% | -39.3% |
| Alpha | +0.4% | -17.7% | -32.0% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBY | SELL | 2022-12-06 | 2022-12-07 | $1.81 | $2 | -17.7% | +14.3% | +16.0% |
| NBY | SELL | 2022-11-21 | 2022-12-05 | $2.10 | $13K | -13.5% | +11.5% | +12.5% |
| NBY | SELL | 2022-09-14 | 2022-09-16 | $0.16 | $47K | -8.9% | -24.1% | -64.1% |
| NBY | BUY | 2021-12-03 | 2021-12-07 | $0.46 | $47K | -2.6% | -22.2% | -44.8% |
| NBY | BUY | 2021-12-02 | 2021-12-06 | $0.48 | $252K | +0.6% | -14.5% | -41.2% |
| NBY | BUY | 2021-12-01 | 2021-12-03 | $0.49 | $7K | +9.9% | -9.4% | -32.2% |
| NBY | BUY | 2021-11-30 | 2021-12-02 | $0.46 | $14K | +0.2% | -15.4% | -36.4% |
| NBY | BUY | 2021-11-22 | 2021-11-24 | $0.46 | $42K | -2.1% | -14.4% | -41.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.